AU2009207927B2 - A new method to measure and characterize microvesicles in the human body fluids - Google Patents

A new method to measure and characterize microvesicles in the human body fluids Download PDF

Info

Publication number
AU2009207927B2
AU2009207927B2 AU2009207927A AU2009207927A AU2009207927B2 AU 2009207927 B2 AU2009207927 B2 AU 2009207927B2 AU 2009207927 A AU2009207927 A AU 2009207927A AU 2009207927 A AU2009207927 A AU 2009207927A AU 2009207927 B2 AU2009207927 B2 AU 2009207927B2
Authority
AU
Australia
Prior art keywords
exosomes
tumor
body fluid
antibody
plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2009207927A
Other languages
English (en)
Other versions
AU2009207927A1 (en
Inventor
Stefano Fais
Mariantonia Logozzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exosomics SpA
Original Assignee
Exosomics SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exosomics SpA filed Critical Exosomics SpA
Publication of AU2009207927A1 publication Critical patent/AU2009207927A1/en
Application granted granted Critical
Publication of AU2009207927B2 publication Critical patent/AU2009207927B2/en
Assigned to EXOSOMICS SIENA S.P.A. reassignment EXOSOMICS SIENA S.P.A. Request for Assignment Assignors: HANSABIOMED OU
Assigned to Exosomics S.p.A. reassignment Exosomics S.p.A. Request to Amend Deed and Register Assignors: EXOSOMICS SIENA S.P.A.
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5751—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AU2009207927A 2008-01-25 2009-01-26 A new method to measure and characterize microvesicles in the human body fluids Ceased AU2009207927B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
USNOTGIVEN 2001-07-05
US6252808P 2008-01-25 2008-01-25
US61/062,528 2008-01-25
US12/321,412 US8617806B2 (en) 2008-01-25 2009-01-21 Method to measure and characterize microvesicles in the human body fluids
PCT/EE2009/000002 WO2009092386A2 (en) 2008-01-25 2009-01-26 A new method to measure and characterize microvesicles in the human body fluids

Publications (2)

Publication Number Publication Date
AU2009207927A1 AU2009207927A1 (en) 2009-07-30
AU2009207927B2 true AU2009207927B2 (en) 2015-04-09

Family

ID=41064551

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2009207927A Ceased AU2009207927B2 (en) 2008-01-25 2009-01-26 A new method to measure and characterize microvesicles in the human body fluids

Country Status (12)

Country Link
US (1) US8617806B2 (https=)
EP (1) EP2245458B1 (https=)
JP (1) JP5583600B2 (https=)
CN (1) CN102317778B (https=)
AU (1) AU2009207927B2 (https=)
BR (1) BRPI0906683B8 (https=)
CA (1) CA2713196C (https=)
ES (1) ES2613670T3 (https=)
MX (1) MX2010008164A (https=)
PL (1) PL2245458T3 (https=)
RU (1) RU2520741C2 (https=)
WO (1) WO2009092386A2 (https=)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100255514A1 (en) 2007-08-16 2010-10-07 The Royal Institution For The Advancement Of Learning/Mcgill University Tumor cell-derived microvesicles
JP5769417B2 (ja) 2007-08-16 2015-08-26 ザ ロイヤル インスティチューション フォー ザ アドバンスメント オブ ラーニング／マギル ユニバーシティ 腫瘍細胞由来微小胞
EP2245199B1 (en) * 2008-02-01 2013-11-13 The General Hospital Corporation Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditions
US9487837B2 (en) * 2008-10-06 2016-11-08 Morehouse School Of Medicine Exosome-mediated diagnosis of hepatitis virus infections and diseases
US10545149B2 (en) * 2008-10-06 2020-01-28 Morehouse School Of Medicine Detection of HIV-related proteins in urine
EP2358912B1 (en) 2008-10-30 2016-10-12 Caris Life Sciences Switzerland Holdings GmbH Methods for assessing rna patterns
GB2463401B (en) 2008-11-12 2014-01-29 Caris Life Sciences Luxembourg Holdings S A R L Characterizing prostate disorders by analysis of microvesicles
WO2011109440A1 (en) * 2010-03-01 2011-09-09 Caris Life Sciences Luxembourg Holdings Biomarkers for theranostics
EP2475989A4 (en) 2009-09-09 2013-02-27 Gen Hospital Corp USE OF MICROVESICLES IN THE ANALYSIS OF KRAS MUTATIONS
WO2011031877A1 (en) 2009-09-09 2011-03-17 The General Hospital Corporation Use of microvesicles in analyzing nucleic acid profiles
CA2782284A1 (en) * 2009-11-30 2011-06-03 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Methods and systems for isolating, storing, and analyzing vesicles
WO2011127219A1 (en) 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings Circulating biomarkers for disease
WO2012006476A2 (en) 2010-07-07 2012-01-12 Aethlon Medical, Inc. Methods and compositions for quantifying exosomes
US20140045915A1 (en) 2010-08-31 2014-02-13 The General Hospital Corporation Cancer-related biological materials in microvesicles
WO2012048372A1 (en) * 2010-10-11 2012-04-19 Medsaic Pty Ltd Assay for disease detection
JP6219721B2 (ja) 2010-11-10 2017-10-25 エキソソーム ダイアグノスティックス インコーポレイテッド 核酸含有粒子の単離および該粒子からの核酸の抽出のための方法
FR2973029B1 (fr) * 2011-03-23 2013-04-26 Centre Nat Rech Scient Complexes metalliques dinucleaires greffes, et leur utilisation en tant que capteurs de microparticules cellulaires
WO2012135844A2 (en) * 2011-04-01 2012-10-04 Cornell University Circulating exosomes as diagnostic/prognostic indicators and therapeutic targets of melanoma and other cancers
EP2715351B1 (en) * 2011-05-24 2016-10-19 The Regents of The University of California Method for exosomal biomarker detection by electric field-induced release and measurement
CN103874770A (zh) * 2011-08-08 2014-06-18 卡里斯生命科学卢森堡控股有限责任公司 生物标志物组合物和方法
US11391741B2 (en) * 2011-12-22 2022-07-19 Theoria Science Inc. Method of exosome analysis, reagent for exosome analysis, and analyzer for exosome
WO2014030590A1 (ja) * 2012-08-24 2014-02-27 国立大学法人東京大学 エキソソームの分析方法、エキソソーム分析装置、抗体－エキソソーム複合体、及びエキソソーム電気泳動チップ
KR101933620B1 (ko) * 2012-09-18 2018-12-28 삼성전자주식회사 소포를 검출하기 위한 조성물, 키트 및 이를 이용하여 소포를 분석하는 방법
US9480714B2 (en) 2012-11-13 2016-11-01 Allan Yang Wu Methods and systems for processing exosomes
CA2904181A1 (en) 2013-03-13 2014-10-09 Anahit Aghvanyan Sandwich immunoassay comprising anchoring reagent
US10114015B2 (en) 2013-03-13 2018-10-30 Meso Scale Technologies, Llc. Assay methods
CN105209881B (zh) 2013-03-13 2021-01-22 迈阿密大学 从细胞培养上清液和生物流体分离并纯化微泡的方法
US12558316B2 (en) 2013-03-13 2026-02-24 University Of Miami Methods and compositions for the treatment of epidermolysis bullosa
JP6210004B2 (ja) 2013-04-09 2017-10-11 株式会社Ｊｖｃケンウッド 試料分析用デバイス及びエクソソームの捕捉方法
WO2015029979A1 (ja) * 2013-08-30 2015-03-05 国立大学法人東京大学 エキソソームの分析方法、エキソソーム分析チップ、及びエキソソーム分析装置
JPWO2015045666A1 (ja) 2013-09-25 2017-03-09 国立大学法人 東京大学 流体デバイス、エキソソームの分析方法、生体分子分析方法及び生体分子検出方法
US10139402B2 (en) 2013-11-06 2018-11-27 Jsr Corporation Separation method, detection method, signal measurement method, method for determining disease, method for evaluating drug efficacy of disease treatment drug, kit, and liquid composition
EP3078889B1 (en) 2013-12-06 2019-09-18 The University of Tokyo Valve, fluid-controlling structure, fluid device, and method for manufacturing valve
WO2015175856A1 (en) * 2014-05-15 2015-11-19 Meso Scale Technologies, Llc. Improved assay methods
WO2015185730A2 (en) * 2014-06-06 2015-12-10 Hansabiomed Ou Exosomal biomarkers
RU2556825C1 (ru) * 2014-09-15 2015-07-20 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Способ получения экзосом из крови
US20160320390A1 (en) * 2015-05-01 2016-11-03 Morehouse School Of Medicine Compositions and methods for capturing exosomes
WO2016186215A1 (ja) * 2015-05-20 2016-11-24 Jsr株式会社 分離方法、検出方法、シグナル測定方法、疾患の判定方法、薬効評価方法、キット、液状組成物及び検体希釈液
WO2016201064A1 (en) 2015-06-09 2016-12-15 The Board Of Regents Of The University Of Texas System Diagnostic test for early stage cancer
JP6606916B2 (ja) 2015-08-21 2019-11-20 株式会社Ｊｖｃケンウッド エクソソームの捕捉方法
GB201518466D0 (en) * 2015-10-19 2015-12-02 Cizzle Biotechnology Ltd Use
CN106093412A (zh) * 2016-06-28 2016-11-09 叶瑞东 一种多肽分子在制备诊断急性脑梗死后微出血的试剂盒中的应用
WO2018070479A1 (ja) * 2016-10-13 2018-04-19 合同会社みらか中央研究所 細胞外小胞の回収方法
RU2682721C2 (ru) * 2016-11-17 2019-03-21 Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран) Биологический микрочип для обнаружения опухолевых экзосом в сыворотке крови человека для диагностики колоректального рака
CN110462404B (zh) * 2017-01-12 2023-06-02 理论科学株式会社 测试受试者患有胰腺癌的可能性的方法
CN106906294A (zh) * 2017-03-31 2017-06-30 浙江大学 一种胞外囊泡/脂质体的定量方法
CN107144688B (zh) * 2017-04-07 2018-09-11 浙江大学 Cd19阳性外泌体作为分子标记在制备肿瘤诊断试剂盒中的应用及试剂盒
JP6573351B2 (ja) 2017-05-29 2019-09-11 国立大学法人神戸大学 検出対象の分析用センサ作製用基材、検出対象の分析用センサ、及び検出対象の分析法
DE102017005543A1 (de) * 2017-06-13 2018-12-13 Forschungszentrum Jülich GmbH Verfahren zum Nachweis von Extrazellulären Vesikeln in einer Probe
CN107907689A (zh) * 2017-10-10 2018-04-13 北京大学 外泌体蛋白cd5l的检测方法
KR101968046B1 (ko) * 2018-07-19 2019-04-11 (주) 바이오인프라생명과학 암의 조기 진단을 위한 복합 바이오마커
JP6677284B2 (ja) * 2018-10-09 2020-04-08 凸版印刷株式会社 分析対象物の検出方法及びラテラルフロー用テストストリップ
AU2020232954B2 (en) 2019-03-01 2026-01-15 Meso Scale Technologies, Llc. Electrochemiluminescent labeled probes for use in immunoassay methods, methods using such and kits comprising same
CN109991427A (zh) * 2019-04-08 2019-07-09 王延博 一种用于检测血清中外泌体表面蛋白标志物的试剂盒
CN110095604B (zh) * 2019-04-12 2022-03-18 南方医科大学南方医院 Caveolin-1蛋白阳性外泌体作为非小细胞肺癌诊断标志物的应用
WO2020241999A1 (ko) * 2019-05-24 2020-12-03 고려대학교 세종산학협력단 스위치 성 부착반응을 이용한 친화 분리 시스템 및 방법
EP4067906A4 (en) * 2019-11-29 2023-04-26 FUJIFILM Wako Pure Chemical Corporation METHODS TO AID THE DIAGNOSIS OF ALZHEIMER'S DISEASE OR MILD COGNITIVE IMPAIRMENT, BIOMARKERS, REAGENT KIT AND DEVICE
CN111537725A (zh) * 2020-05-29 2020-08-14 武汉大学 高效定量检测细胞外囊泡中pd-1水平的方法、elisa试剂盒及使用方法
DE102021208893B3 (de) 2021-08-13 2022-11-17 Hahn-Schickard-Gesellschaft für angewandte Forschung e.V. Isolieren von Analyten unterschiedlicher Analyt-Klassen

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2453198A1 (en) * 2004-01-07 2005-07-07 Wei-Ping Min Quantification and generation of immune suppressive exosomes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH081438B2 (ja) * 1986-05-13 1996-01-10 三洋化成工業株式会社 酵素免疫測定法
EP1004664A1 (en) * 1998-11-24 2000-05-31 Institut National De La Sante Et De La Recherche Medicale (Inserm) Compositions and methods using lactadherin or variants thereof
GB9927320D0 (en) * 1999-11-18 2000-01-12 Chiron Spa Exosome separation
US20040241176A1 (en) * 2000-04-27 2004-12-02 Ap Cells. Inc. Method of producing membrane vesicles
US6812023B1 (en) * 2000-04-27 2004-11-02 Anosys, Inc. Methods of producing membrane vesicles
US7442777B2 (en) * 2000-11-29 2008-10-28 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of CD63
US20030190602A1 (en) * 2001-03-12 2003-10-09 Monogen, Inc. Cell-based detection and differentiation of disease states
AU2003214944A1 (en) 2002-01-31 2003-09-02 Baylor College Of Medicine Secreted caveolin as a marker for prostate cancer
JP2005237234A (ja) * 2004-02-25 2005-09-08 Japan Science & Technology Agency カベオリン抗原とその用途
AU2007243184A1 (en) * 2006-04-28 2007-11-08 University Of Iowa Research Foundation Methods and compounds to modulate parvovirus transduction of mammalian cells or to alter virus infection, method to identify a viral receptor or co-receptor
US20120058492A1 (en) * 2008-01-25 2012-03-08 Hansabiomed Ou Method and a Kit To Detect Malignant Tumors and Provide a Prognosis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2453198A1 (en) * 2004-01-07 2005-07-07 Wei-Ping Min Quantification and generation of immune suppressive exosomes

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ADMYRE, C. et al. Journal of Allergy and Clinical Immunology, 2007, Vol.120, p.1418-1424 *
KOGA, K. et al. Anticancer Research, 2005, Vol.25, p.3703-3708 *

Also Published As

Publication number Publication date
AU2009207927A1 (en) 2009-07-30
CN102317778B (zh) 2015-05-13
EP2245458B1 (en) 2016-10-26
BRPI0906683B1 (pt) 2021-03-02
BRPI0906683B8 (pt) 2021-07-27
CA2713196C (en) 2014-06-17
CA2713196A1 (en) 2009-07-30
WO2009092386A2 (en) 2009-07-30
JP5583600B2 (ja) 2014-09-03
BRPI0906683A2 (pt) 2017-08-22
JP2011510309A (ja) 2011-03-31
RU2010135526A (ru) 2012-02-27
EP2245458A2 (en) 2010-11-03
CN102317778A (zh) 2012-01-11
PL2245458T3 (pl) 2017-08-31
US20090220944A1 (en) 2009-09-03
US8617806B2 (en) 2013-12-31
RU2520741C2 (ru) 2014-06-27
WO2009092386A8 (en) 2010-10-14
MX2010008164A (es) 2010-11-25
ES2613670T3 (es) 2017-05-25
WO2009092386A3 (en) 2009-09-17

Similar Documents

Publication Publication Date Title
AU2009207927B2 (en) A new method to measure and characterize microvesicles in the human body fluids
Bergmann et al. Tumor‐derived microvesicles in sera of patients with head and neck cancer and their role in tumor progression
Nawaz et al. Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery
Laurent et al. Distribution, function, and prognostic value of cytotoxic T lymphocytes in follicular lymphoma: a 3-D tissue-imaging study
Vargas et al. Syncytin proteins incorporated in placenta exosomes are important for cell uptake and show variation in abundance in serum exosomes from patients with preeclampsia
Stoeck et al. A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44
Lindner et al. Interleukin 21–induced granzyme B–expressing B cells infiltrate tumors and regulate T cells
Cao et al. Plasma soluble HLA‐G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer
CN102301236B (zh) 方法
US20160370265A1 (en) Method for isolating exosomes
US11561223B2 (en) Method and system for identifying membrane proteins on extracellular vesicles
US20210017607A1 (en) Methods of Predicting Responsiveness to Cancer Therapies
WO2015189395A1 (en) Methods and compositions for diagnosing, monitoring and treating cancer
JP2016532865A (ja) エフェクターｔレグ細胞を同定するための方法及びキット
US20160334402A1 (en) Method for analyzing markers on the surface of vesicles
Tzaridis et al. A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression
Grange et al. Phenotypic characterization and functional analysis of human tumor immune infiltration after mechanical and enzymatic disaggregation
WO2013107826A2 (en) Use of cellular biomarkers expression to diagnose sepsis among intensive care patients
JP2019518226A (ja) 受容体シナジー活性を利用したｎｋ細胞の活性度検査方法、及びそれを利用したｎｋ細胞の活性度が関連する疾患の診断方法
Iizuka et al. Anti-vascular endothelial growth factor receptor (VEGFR) 2 autoantibody identification in glioblastoma patient using single B cell-based antibody gene cloning
Eroğlu Characterization of Functional and Molecular Properties of Circulating Extracellular Vesicles of Childhood Idiopathic Nephrotic Syndrome Patients
Teeuwen Optimizing the therapeutic potential of extracellular vesicles in cancer
Bergstrom Identification of altered cell surface glycoproteins and micropattern assay development in the context of human malignancies
Ham The role of breast cancer derived-exosomes in the tumour micro-environment
Lau et al. Fucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: EXOSOMICS SIENA S.P.A.

Free format text: FORMER OWNER(S): HANSABIOMED OU

HB Alteration of name in register

Owner name: EXOSOMICS S.P.A.

Free format text: FORMER NAME(S): EXOSOMICS SIENA S.P.A.

MK14 Patent ceased section 143(a) (annual fees not paid) or expired